SecBot

SecBot
PRE-MARKET · WED · APR 29 · 2026 · 07:39 ET ·REGIME · CALM

Tech megacap earnings gauntlet kicks off with MSFT/META AMC; semis pull back on AMD overheating while VIX collapses to 17.9 from March's 30+ stress peak.

SecBot Research
01Executive Summary
  • Pre-market tape leans defensive: SPX futures imply continuation of yesterday's -0.49% slip, with semis (AMD -3.4%, NVDA -1.2%) and megacap tech (META -1.1%) leading lower into mega-cap earnings.
  • MSFT (+1.0%) is the standout pre-market megacap green print, setting up a binary catalyst tonight AMC after a wave of analyst PT cuts (BMO, Oppenheimer, Mizuho) that have already de-rated expectations.
  • UNH (+3.4%) and INTC (+1.6%) lead pre-market gainers; healthcare bid arrives off oversold conditions while semis derate.
  • Macro backdrop is unambiguously CALM — VIX 17.9, HY spreads 2.84%, financial stress index -0.76 — but Gold $4,580 and Oil $103 carry residual geopolitical premium worth monitoring.
  • Heavy Q1 earnings flow Tuesday/Wednesday: GD (+12% YoY EPS, 2:1 book/bill), GNRC (raised guidance), CSTM (+57% beat), EXE (+32% beat), with notable misses at ASH and TPH.
  • Russell 2000 outperforming on technicalScore (+36.6) ahead of large-cap indices — small-cap leadership rotation continues with RUT up +14.2% over trailing 30 days vs SPX +12.5%.
02Market Snapshot
S&P 500
7,138.80
▼ -0.49% -35.11
30D +12.5%
Nasdaq
24,663.80
▼ -0.90% -223.30
30D +18.6%
Dow Jones
49,141.93
▼ -0.05% -25.86
30D +8.7%
Russell 2000
2,756.05
▼ -1.15% -32.14
30D +14.2%
VIX
17.91
▲ +0.45% +0.08
30D -41.5%
03Sector & Breadth
Leaders
Technology (XLK)
+0.4%
Communication Services (XLC)
+0.2%
Consumer Discretionary (XLY)
+0.1%
Energy (XLE)
+0.1%
Laggards
Health Care (XLV)
-1.2%
Materials (XLB)
-0.5%
Utilities (XLU)
-0.3%
A/D 1.1:1 Advancers : decliners — ratio of rising to falling stocks on the session.
Volume Roughly in-line with 20-day average Today's NYSE composite volume vs. the 10-day average. 1.0× = normal.
52W Hi 142 Stocks closing at a new 52-week high today.
52W Lo 38 Stocks closing at a new 52-week low today.
04ETF Flows
Inflows
MOO VanEck Agribusiness
+$367M (3m)
COPX Global X Copper Miners
+$780M (3m)
UNG United States Natural Gas Fund
+$176M (3m)
TAN Invesco Solar
+$175M (3m)
GDX VanEck Gold Miners
+$795M (3m)
Outflows
GLD SPDR Gold Shares
-$2.4B (5d)
LQD iShares iBoxx IG Bonds
-$3.1B (5d)
EMB iShares EM Bonds
-$259M (5d)
COWZ Pacer US Cash Cows 100
-$462M (3m)
VGK Vanguard FTSE Europe
-$532M (1m)
05Biggest Movers
Gainers
UNH ▲ +3.4%
UnitedHealth Group
Healthcare sector bid following multi-week selloff; oversold reversal off RSI lows
INTC ▲ +1.6%
Intel
Continued recovery momentum; Silicon Motion's +105% YoY revenue print supports semi infrastructure thesis
MSFT ▲ +1.0%
Microsoft
Bid into Q3 FY26 earnings tonight AMC; analyst PT cuts (BMO, Oppenheimer, Mizuho) have already reset expectations
NFLX ▲ +1.0%
Netflix
Stochastic oversold bounce off SMA50 region; technical mean-reversion trade
Losers
AMD ▼ -3.4%
Advanced Micro Devices
Pre-market profit-taking from RSI-73 overbought conditions; semis broadly weaker into mega-cap earnings
NVDA ▼ -1.2%
NVIDIA
Sympathy weakness with AMD pullback; broader semi de-risking ahead of mega-cap tech earnings
META ▼ -1.1%
Meta Platforms
De-risking ahead of earnings after-hours; SMA200 ($679.50) acting as overhead resistance
06Key Drivers
  1. 01 Mega-cap tech earnings start tonight: MSFT reports AMC, with consensus Q3 EPS $4.07 / revenue $81.4B; revisions skewed positive (7d: +1 up / 0 down) but analyst price targets have been cut 21x in last 30 days — bar reset.
  2. 02 Strong Q1 beats reported pre-market: GD +12% YoY EPS with 2:1 book-to-bill; GNRC raised 2026 guidance (mid-to-high teens revenue growth); CSTM +57% beat with raised EBITDA guide.
  3. 03 VIX collapse from 30.6 (3/30) to 17.9 today (-41.5% in 30 days) marks decisive regime shift back to CALM; HY spreads at 2.84% confirm risk appetite.
  4. 04 Oil persistently elevated at $103.39 and Gold at $4,580 — commodity bid uncoupled from VIX, signaling residual geopolitical premium without credit-market stress.
  5. 05 Healthcare leadership flip: XLV technicalScore -27 (sell) vs XLK +36 (buy); UNH pre-market +3.4% potentially marks oversold capitulation reversal.
  6. 06 Russell 2000 outperformance continues with technicalScore +36.6 (top index rank); priceVsSMA200 +10.7% suggests sustained small-cap broadening.
  7. 07 Notable single-name misses: ASH -72% EPS miss with FY guide cut; TPH -89% net income decline; NOV -64% miss on Middle East disruption.
07Technical Analysis
S&P 500
S&P 500 7,138.80 — bullish trend (moderate), RSI 66.9, score +20.9 (buy). Nearest support 7,046.55, resistance 7,163.13 (just overhead). Holding above SMA200 by 6.3%; MACD bullish.
Nasdaq
Nasdaq 24,663.80 — bullish, RSI 68.2 approaching overbought, score +31.4 (buy). Support 24,198.99, resistance 24,899.37 (52-week high cluster). priceVsSMA200 +8.9%.
VIX
VIX 17.91 — score -8.1, bearish trend, RSI 39.9. Sitting just above support 17.57; resistance 18.50. Volatility regime decisively CALM but room to compress further if mega-cap earnings clear.
  • Russell 2000 score +36.6 (top index rank), RSI 63 with priceVsSMA200 +10.7%; support 2,741.54, resistance 2,817.96 (52-week high) — small-cap leadership intact.
  • Dow Jones score +14.6 (neutral), RSI 61.9; support 48,754.82, resistance 49,711.64. Lagging on technicals but breadth supportive.
  • XLK +36.4 (top sector), XLV -27.4 (lone sell); breadth defensible but rotational.
08Cross-Market
US Treasuries
10-year yield 4.354% (+13.8bp); 2-year 3.78%; curve +52bp positive. 30-year 4.94%.
FX
DXY 98.68 (-0.6 from prior session) — soft dollar regime; 52w range 95.6–101.98.
Commodities
Oil (CL=F) $103.39 (+0.5%), Gold (GC=F) $4,579.70 (-0.6%), Copper $5.97. Commodity bid persists despite VIX collapse.
Europe / Asia
Euro Stoxx 50 5,816.68 (+0.3% intraday); Nikkei 225 closed at 59,917.46 — within 1.6% of 52w high of 60,903.95. Risk-on tone in Europe and Asia.
Other
BTC $77,523 (+1.6%), ETH $2,330 (+2.4%), DOGE +11%; crypto bid suggests risk appetite alive.
09Upcoming Calendar
Economic 4
08:15 ET
ADP Employment Change (April)
+125K (consensus); prior +155K
08:30 ET
GDP (Q1 advance estimate)
+1.8% q/q SAAR (consensus); prior +2.4%
10:00 ET
Pending Home Sales (March)
+0.5% m/m (consensus); prior -2.0%
10:30 ET
EIA Crude Oil Inventories
Build of ~1.5M bbl (consensus)
Earnings 6
MSFT Microsoft Corp. AMC
Apr 29, 2026
EPS $4.07 · Rev $81.4B
Prior: Beat by $0.05; revenue beat
Azure growth pace and AI-capex commentary set the tone for entire mega-cap tech earnings cycle; PT cuts have already de-rated bar.
META Meta Platforms AMC
Apr 29, 2026
EPS $5.25 · Rev $41.4B
Prior: Beat
Reality Labs spending and ad pricing trajectory; pre-market -1.1% suggests positioning concern.
GD General Dynamics BMO
Apr 29, 2026
EPS $3.65 · Rev $12.3B
Prior: Beat
Reported pre-market: EPS $4.10 (+12% YoY), 2:1 book-to-bill, defense backlog strong.
GNRC Generac Holdings BMO
Apr 29, 2026
EPS $1.33 · Rev $1.05B
Prior: Beat
Reported pre-market: EPS $1.61 beat, raised 2026 guidance to mid-to-high teens revenue growth on data-center backlog.
ETSY Etsy Inc. BMO
Apr 29, 2026
EPS $0.45 · Rev $629M
Discretionary read into consumer spending; e-commerce sector pulse.
ADP Automatic Data Processing BMO
Apr 29, 2026
EPS $3.05 · Rev $5.6B
Payroll-services labor-market read coincident with ADP private payrolls release.
Biotech Catalysts 3
MESO Mesoblast Limited
Phase 3 fully enrolled; RMAT-designated
Phase 3 readout (advance) · Top-line mid-2027; FDA filing target Q3 2027
Chronic low back pain (degenerative disc disease)
Targets 7M+ U.S. patient pool; RMAT enables priority review pathway.
ACRS Aclaris Therapeutics
Phase 1a complete (positive)
Phase 2b basket study start · H2 2026
Lichen planus (ATI-2138 ITK/JAK3 inhibitor)
Pipeline de-risking; Phase 1a results showed 45-day half-life enabling Q3M dosing.
WVE Wave Life Sciences
Phase 2a accepted by FDA
AATD interim data + WVE-007 Phase 2a IND acceptance · Data in 2026
Alpha-1 antitrypsin deficiency / obesity (GalNAc-INHBE)
Wave's $544M cash position and recent revenue beat support pipeline progression; INHBE program is potential GLP-1 alternative.
10 Stocks in Focus Quotes as of 21:00 ET

Names in focus based on expected market-moving catalysts and technical setups. Descriptive commentary only — not investment advice or a recommendation to buy or sell any security.

MSFT
Microsoft Corp.
▲UPSIDE Moderate PROB EARNINGS
$429.25 ▲ +1.0% 24h
Price at report release
Setting up into Q3 FY26 earnings tonight AMC with bar already reset by 21 PT cuts in last 30 days (BMO, Oppenheimer, Mizuho all lowered targets while maintaining Buy). EPS revisions trending positive (7d: +1/0) and pre-market bid (+1.0%) suggests positioning leans constructive into Azure/AI-capex commentary.
Resistance
$432.64+0.8% ↑
▶$429.25Now
Support
$421.02−1.9% ↓
UNH
UnitedHealth Group
▲UPSIDE Moderate PROB TECHNICAL
$366.77 ▲ +3.4% 24h
Price at report release
Healthcare oversold reversal in motion — UNH +3.4% pre-market is the largest non-crypto gainer with technicalScore +37.5 (buy) and bullish trend strong. Caveat: RSI at 84.4 is severely overbought, demoting probability — pullback risk into resistance at $373.63 (just 1.9% away) is real.
Resistance
$373.63+1.9% ↑
▶$366.77Now
Support
$352.33−3.9% ↓
GNRC
Generac Holdings
▲UPSIDE High PROB EARNINGS
$217.12 ▼ -1.4% 24h
Price at report release
Post-print breakout setup: Q1 EPS $1.61 vs $1.33 consensus (+21% beat) on 12% revenue growth, with 2026 guidance raised to mid-to-high teens revenue and EBITDA margins to 18.5–19.5%. Data-center backlog and Enercon contribution drive upgrade. Score +29 with bullish MACD; resistance $219.99 within 1.3%.
Resistance
$219.99+1.3% ↑
▶$217.12Now
Support
$200.32−7.7% ↓
GD
General Dynamics
▲UPSIDE Moderate PROB EARNINGS
$313.68 ▲ +0.4% 24h
Price at report release
Strong Q1 print this morning — EPS $4.10 (+12% YoY), revenue $13.5B (+10.3%), 2:1 book-to-bill across all four segments — lands into oversold technicals (RSI 26.99, score -38.3). Heavy technical headwind acknowledged but fundamental beat may catalyze short-cover rally off support $310.16. Defense theme corroborated by elevated commodity/geopolitical premium.
Resistance
$319.36+1.8% ↑
▶$313.68Now
Support
$310.16−1.1% ↓
META
Meta Platforms
▼DOWNSIDE Moderate PROB EARNINGS
$671.34 ▼ -1.1% 24h
Price at report release
Watching for further give-back into earnings AMC: pre-market -1.1% with stock pinned below SMA200 at $679.50 (resistance) and momentum6m -10.6%. Reality Labs spend and ad-pricing commentary into a Bollinger-position 70% setup leaves asymmetric downside if guide is conservative. Support $649.36 (3.3% below) is the line in the sand.
Resistance
$680.01+1.3% ↑
▶$671.34Now
Support
$649.36−3.3% ↓
11Outlook
Pre-market setup leans defensive with semis (-AMD/-NVDA) and mega-cap social leading lower into the year's most consequential earnings night. The CALM regime classification (VIX 17.9, HY 2.84%, F&G 64) keeps micro-signal weighting intact — earnings reactions, not macro headlines, will drive single-name dispersion. Watch SPX 7,046.55 support as the line that defines whether mega-cap earnings-night risk transmits broadly or stays contained at the tech level. Top risk: a soft Azure or AI-capex print from MSFT after the close could re-rate the entire AI-infrastructure complex, while Gold at $4,580 and Oil at $103 remain a reminder that geopolitical premium can resurface even with credit markets sanguine.
Important Disclosures

This report is for informational and educational purposes only. It is not investment advice, a research report within the meaning of applicable securities regulations, or a recommendation, solicitation, or offer to buy or sell any security.

References to expected price moves, support and resistance levels, or names "in focus" are descriptive observations about market conditions and expected behaviour — not directives to take a position. SecBot is not a registered investment adviser, broker-dealer, or financial planner. Past performance does not indicate future results. Any investment decisions are solely your own and you should consult a qualified financial professional who understands your individual circumstances before acting on any information herein.

SecBot and its affiliates may hold positions in securities mentioned. Figures are sourced from third-party data providers and may contain errors; readers should independently verify before relying on any specific number.